Cargando…
Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms
OBJECTIVES: The Sendai guidelines for management of patients with clinically suspected intraductal papillary mucinous neoplasms (IPMN) recommend resection of cysts > 30 mm, a dilated main pancreatic duct (MPD) > 6 mm, a mural nodule (MN), symptoms or positive cytology. Although sensitive, asym...
Autores principales: | Ono, Jill, Yaeger, Kurt A., Genevay, Muriel, Mino-Kenudson, Mari, Brugge, William R., Pitman, Martha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229770/ https://www.ncbi.nlm.nih.gov/pubmed/22145009 http://dx.doi.org/10.4103/1742-6413.90084 |
Ejemplares similares
-
Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resection
por: Hackert, Thilo, et al.
Publicado: (2015) -
Surgical outcomes of multifocal branch duct intraductal papillary mucinous neoplasms of pancreas
por: Kwon, Jae Hyun, et al.
Publicado: (2014) -
Risk stratification tools for branch‐duct intraductal papillary mucinous neoplasms of the pancreas
por: Balduzzi, Alberto, et al.
Publicado: (2022) -
Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms
por: Xu, Yisheng, et al.
Publicado: (2022) -
Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms
por: Torisu, Yuichi, et al.
Publicado: (2019)